Gene therapy for hemophilia involves using a modified virus (which does not cause disease) to introduce a copy of the gene that encodes for the clotting factor that's missing in patients. Following treatment with the virus, patients should begin producing their own clotting factor normally.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Hemophilia Gene Therapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Hemophilia A
Hemophilia B
Market Segment by Product Application
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy
Finally, the report provides detailed profile and data information analysis of leading company.
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Hemophilia Gene Therapy consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Hemophilia Gene Therapy market by identifying its various subsegments.
3.Focuses on the key global Hemophilia Gene Therapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Hemophilia Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Hemophilia Gene Therapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Hemophilia Gene Therapy Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Hemophilia Gene Therapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Hemophilia Gene Therapy Segment by Type
2.1.1 Hemophilia A
2.1.2 Hemophilia B
2.2 Market Analysis by Application
2.2.1 Hemophilia A Gene Therapy
2.2.2 Hemophilia B Gene Therapy
2.3 Global Hemophilia Gene Therapy Market Comparison by Regions (2016-2026)
2.3.1 Global Hemophilia Gene Therapy Market Size (2016-2026)
2.3.2 North America Hemophilia Gene Therapy Status and Prospect (2016-2026)
2.3.3 Europe Hemophilia Gene Therapy Status and Prospect (2016-2026)
2.3.4 China Hemophilia Gene Therapy Status and Prospect (2016-2026)
2.3.5 Japan Hemophilia Gene Therapy Status and Prospect (2016-2026)
2.3.6 Southeast Asia Hemophilia Gene Therapy Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Hemophilia Gene Therapy Industry Impact
2.5.1 Hemophilia Gene Therapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Hemophilia Gene Therapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Hemophilia Gene Therapy Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Hemophilia Gene Therapy Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Hemophilia Gene Therapy Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Hemophilia Gene Therapy Manufacturer Market Share
3.5 Top 10 Hemophilia Gene Therapy Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Hemophilia Gene Therapy Market
3.7 Key Manufacturers Hemophilia Gene Therapy Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Hemophilia Gene Therapy Industry Key Manufacturers
4.1 Spark Therapeutics
4.1.1 Compan Detail
4.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Introduction, Application and Specification
4.1.3 Spark Therapeutics 132 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Spark Therapeutics News
4.2 Ultragenyx
4.2.1 Compan Detail
4.2.2 Ultragenyx Hemophilia Gene Therapy Product Introduction, Application and Specification
4.2.3 Ultragenyx Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Spark Therapeutics News
4.3 Shire PLC
4.3.1 Compan Detail
4.3.2 Shire PLC Hemophilia Gene Therapy Product Introduction, Application and Specification
4.3.3 Shire PLC Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Shire PLC News
4.4 Sangamo Therapeutics
4.4.1 Compan Detail
4.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Introduction, Application and Specification
4.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Sangamo Therapeutics News
4.5 Bioverativ
4.5.1 Compan Detail
4.5.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Introduction, Application and Specification
4.5.3 Bioverativ Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Bioverativ News
4.6 BioMarin
4.6.1 Compan Detail
4.6.2 BioMarin Hemophilia Gene Therapy Product Introduction, Application and Specification
4.6.3 BioMarin Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 BioMarin News
4.7 uniQure
4.7.1 Compan Detail
4.7.2 uniQure Hemophilia Gene Therapy Product Introduction, Application and Specification
4.7.3 uniQure Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Freeline Therapeutics
4.8.1 Compan Detail
4.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Introduction, Application and Specification
4.8.3 Freeline Therapeutics Hemophilia Gene Therapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Freeline Therapeutics News
5 Global Hemophilia Gene Therapy Market Segment by Big Type
5.1 Global Hemophilia Gene Therapy Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Hemophilia Gene Therapy Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Hemophilia Gene Therapy Revenue and Market Share by Big Type (2016-2021)
5.2 Hemophilia A Sales Growth Rate and Price
5.2.1 Global Hemophilia A Sales Growth Rate (2016-2021)
5.2.2 Global Hemophilia A Price (2016-2021)
5.3 Hemophilia B Sales Growth Rate and Price
5.3.1 Global Hemophilia B Sales Growth Rate (2016-2021)
5.3.2 Global Hemophilia B Price (2016-2021)
6 Global Hemophilia Gene Therapy Market Segment by Big Application
6.1 Global Hemophilia Gene Therapy Sales Market Share by Big Application (2016-2021)
6.2 Hemophilia A Gene Therapy Sales Growth Rate (2016-2021)
6.3 Hemophilia B Gene Therapy Sales Growth Rate (2016-2021)
7 Global Hemophilia Gene Therapy Forecast
7.1 Global Hemophilia Gene Therapy Revenue, Sales and Growth Rate (2021-2026)
7.2 Hemophilia Gene Therapy Market Forecast by Regions (2021-2026)
7.2.1 North America Hemophilia Gene Therapy Market Forecast (2021-2026)
7.2.2 Europe Hemophilia Gene Therapy Market Forecast (2021-2026)
7.2.3 China Hemophilia Gene Therapy Market Forecast (2021-2026)
7.2.4 Japan Hemophilia Gene Therapy Market Forecast (2021-2026)
7.2.5 Southeast Asia Hemophilia Gene Therapy Market Forecast (2021-2026)
7.2.6 Other Regions Hemophilia Gene Therapy Market Forecast (2021-2026)
7.3 Hemophilia Gene Therapy Market Forecast by Type (2021-2026)
7.3.1 Global Hemophilia Gene Therapy Sales Forecast by Type (2021-2026)
7.3.2 Global Hemophilia Gene Therapy Market Share Forecast by Type (2021-2026)
7.4 Hemophilia Gene Therapy Market Forecast by Application (2021-2026)
7.4.1 Global Hemophilia Gene Therapy Sales Forecast by Application (2021-2026)
7.4.2 Global Hemophilia Gene Therapy Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Hemophilia Gene Therapy Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Hemophilia Gene Therapy Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Hemophilia Gene Therapy
Figure Market Concentration Ratio and Market Maturity Analysis of Hemophilia Gene Therapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Hemophilia Gene Therapy Market Size by Big Type
Figure Global Market Share of Hemophilia Gene Therapy by Big Type in 2020
Figure Hemophilia A Picture (2016-2021)
Global Hemophilia Gene Therapy Market Size by Big Application
Table Global Hemophilia Gene Therapy Market Size by Application
Figure Global Hemophilia Gene Therapy Market Share by Big Application in 2020
Figure Hemophilia A Gene Therapy Picture
Figure Hemophilia B Gene Therapy Picture
Table Global Hemophilia Gene Therapy Comparison by Regions (M USD) ?2016-2026?
Figure Global Hemophilia Gene Therapy Market Size (Million US$) (2016-2026)
Figure North America Hemophilia Gene Therapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Hemophilia Gene Therapy Revenue (Million US$) Growth Rate (2016-2026)
Figure China Hemophilia Gene Therapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Hemophilia Gene Therapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Hemophilia Gene Therapy Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Hemophilia Gene Therapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Hemophilia Gene Therapy Sales by Manufacturer (2016-2021)
Figure Global Hemophilia Gene Therapy Sales Market Share by Manufacturer in 2020
Table Global Hemophilia Gene Therapy Revenue by Manufacturer (2016-2021)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Manufacturer in 2020
Table Global Hemophilia Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hemophilia Gene Therapy Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Hemophilia Gene Therapy Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Hemophilia Gene Therapy Market
Table Key Manufacturers Hemophilia Gene Therapy Product Type
Table Mergers & Acquisitions Planning
Table Spark Therapeutics Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Spark Therapeutics
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Ultragenyx Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Ultragenyx
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Ultragenyx Recent Development
Table Shire PLC Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Shire PLC
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Shire PLC Main Business
Table Shire PLC Recent Development
Table Sangamo Therapeutics Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Sangamo Therapeutics
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Sangamo Therapeutics Main Business
Table Sangamo Therapeutics Recent Development
Table Sangamo Therapeutics Main Business
Table Sangamo Therapeutics Recent Development
Table Bioverativ Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Bioverativ
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bioverativ Main Business
Table Bioverativ Recent Development
Table BioMarin Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of BioMarin
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table BioMarin Main Business
Table BioMarin Recent Development
Table uniQure Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of uniQure
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table uniQure Main Business
Table uniQure Recent Development
Table Freeline Therapeutics Company Profile
Table Hemophilia Gene Therapy Product Introduction, Application and Specification of Freeline Therapeutics
Table Hemophilia Gene Therapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Freeline Therapeutics Main Business
Table Freeline Therapeutics Recent Development
Figure Global Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure Global Hemophilia Gene Therapy Revenue and Growth Rate (2016-2021)
Table Global Hemophilia Gene Therapy Sales by Regions (2016-2021)
Figure Global Hemophilia Gene Therapy Sales Market Share by Regions in 2020
Table Global Hemophilia Gene Therapy Revenue by Regions (2016-2021)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Regions in 2020
Figure North America Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure Europe Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure China Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure Japan Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Figure Other Regions Hemophilia Gene Therapy Sales and Growth Rate (2016-2021)
Table Global Hemophilia Gene Therapy Sales by Big Type (2016-2021)
Table Global Hemophilia Gene Therapy Sales Market Share by Big Type (2016-2021)
Figure Global Hemophilia Gene Therapy Sales Market Share by Big Type in 2019
Table Global Hemophilia Gene Therapy Revenue by Big Type (2016-2021)
Table Global Hemophilia Gene Therapy Revenue Market Share by Big Type (2016-2021)
Table Global Hemophilia Gene Therapy Revenue Market Share by Big Type in 2019
Figure Global Hemophilia A Sales Growth Rate (2016-2021)
Figure Global Hemophilia A Price (2016-2021)
Figure Global Hemophilia B Sales Growth Rate (2016-2021)
Table Global Hemophilia Gene Therapy Sales by Big Application (2016-2021)
Table Global Hemophilia Gene Therapy Sales Market Share by Big Application (2016-2021)
Figure Global Hemophilia Gene Therapy Sales Market Share by Big Application in 2019
Figure Global Hemophilia A Gene Therapy Sales Growth Rate (2016-2021)
Figure Global Hemophilia B Gene Therapy Sales Growth Rate (2016-2021)
Figure Global Hemophilia Gene Therapy Sales and Growth Rate (2021-2026)
Figure Global Hemophilia Gene Therapy Revenue and Growth Rate (2021-2026)
Table Global Hemophilia Gene Therapy Sales Forecast by Regions (2021-2026)
Table Global Hemophilia Gene Therapy Market Share Forecast by Regions (2021-2026)
Figure North America Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Figure Europe Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Figure China Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Figure Japan Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Figure Southeast Asia Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Figure Other Regions Sales Hemophilia Gene Therapy Market Forecast (2021-2026)
Table Global Hemophilia Gene Therapy Sales Forecast by Type (2021-2026)
Table Global Hemophilia Gene Therapy Market Share Forecast by Type (2021-2026)
Table Global Hemophilia Gene Therapy Sales Forecast by Application (2021-2026)
Table Global Hemophilia Gene Therapy Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Gene Therapy
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Hemophilia Gene Therapy Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hemophilia Gene Therapy Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hemophilia Gene Therapy Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hemophilia Gene Therapy Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hemophilia Gene Therapy Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hemophilia Gene Therapy Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hemophilia Gene Therapy Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hemophilia Gene Therapy Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
+16467917070US (Toll Free)
